Table 4.

Logistic models for “disease monitoring” outcome, Navajo Nation, United States, 2010–2014

Rate of received “acceptable” disease monitoring	Intervention	OR	95% CI
48.92% in COPE	COPE vs non-COPE a	0.85	0.63, 1.15
52.89% in non-COPE	COPE vs non-COPE b	0.93	0.68, 1.26

COPE Community Outreach and Patient Empowerment, OR Odds ratio, CI confidence interval

^a Model adjusted for baseline monitoring disease (indicator variable that takes value 1 if HbA1c, LDL, and SBP, are all measured at least once in the 12 months before the enrollment date, and 0 otherwise)

^b Adjusted model for baseline monitoring disease, age (years; continuous), gender (male/female), preferred language (English, Navajo and other), primary care physician (yes/no); essential hypertension (yes/no), major depression disorder (yes/no), alcohol abuse (yes/no), dyslipidemia (yes/no), and major cardiovascular disease (yes/no)

Models evaluate the probability of having glycosylated hemoglobin (HbA1c), low-density lipoprotein (LDL), and systolic blood pressure (SBP), all been measured at least once between 12 and 24 months after the enrollment date